tbuckley/cabot-search huggingface dataset:
Thromboelastography-Guided Resuscitation of the Trauma Patient
Authors: Madhu Subramanian, Lewis J. Kaplan, Jeremy W. Cannon
Journal: JAMA Surgery (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Anemia before chemotherapy associated with quality of life in breast cancer patients: A preliminary study
Authors: Olivia J.D.A. Saroso, Wilson M. Raffaello, Julang Fahman, Felix Wijovi, Helenia Putri, Fernando Dharmaraja, Michelle Octavia, Maria Claudia, Cindy Cindy, Andree Kurniawan
Journal: Annals of Oncology (2019)
Transformation of grade II to grade III rhabdoid-papillary meningioma: Is SRS the culprit?
Authors: Ioannis Christodoulides, Jose Pedro Lavrador, Francesco Vergani, Ranjeev Bhangoo, Richard Gullan, Keyoumars Ashkan
Journal: Neuro-Oncology (2019)

Abstract Objectives Meningiomas demonstrate specific genetic and epigenetic mutations, whose effect on recurrence and progression is still of limited understanding. Single-fraction stereotactic radiosurgery (SRS) is an established alternative treatment to surgical resection, proven to achieve excellent local disease control with minimal side effects. However, its effects on tumorigenesis and malignant transformation are still uncertain. The published estimated risk ranges from 0.04%-2.6% at 15 years. Design Case report Subjects Female patient referred to our neurosurgical service Methods Retrospective analysis of patient’s notes, histopathology reports, clinic letters, MDT decisions and imaging studies Results This report describes a case of a grade II parafalcine meningioma, that was initially resected with a Simpson 2 clearance, and upon recurrence, was managed with a single dose of SRS. More than 7 years later, the meningioma recurred, and due to its increasing size on follow-up imaging, it was re-resected. Histopathology revealed a grade III rhabdoid-papillary lesion, with local brain invasion. Conclusions To our knowledge, this was the first report to describe malignant transformation of a grade II to a grade III meningioma following SRS therapy to date. Therefore, considering the recent trend towards SRS-treatment for meningiomas, the treating team should always consider its potential effects on tumorigenesis.
PVRL2 Is Translocated to the TCRA Locus in t(14;19)(q11;13) Positive Peripheral T-Cell Lymphoma.
Authors: Carole Almire, Philippe Ruminy, Philippe Bertrand, Iwona Wlodarska, Jose I. Martin Subero, Reiner Siebert, Herve Tilly, Christian Bastard
Journal: Blood (2006)
The Para-Isomer of Nitric Oxide Donating Acetylsalicylic Acid (p-NO-ASA) Induces Apoptosis in Chronic Lymphocytic Leukemia (CLL) in Vitro and In Vivo without Gross Systemic Toxicities.
Authors: Regina Razavi, Iris Gehrke, Rajesh Kumar Gandhirajan, Simon Jonas Poll-Wolbeck, Julian Paesler, Felix Erdfelder, Magdalena Hertweck, Alexandra Filipovich, Sabrina Uhrmacher, Michael Hallek, Karl Anton Kreuzer
Journal: Blood (2009)
Trends in Sexual Risk Behaviors Among Hispanic/Latino Men Who Have Sex with Men — 19 Urban Areas, 2011–2017
Authors: Lindsay Trujillo, Johanna Chapin-Bardales, Emilio J. German, Dafna Kanny, Cyprian Wejnert, Meaghan Abrego, Alia Al-Tayyib, Bridget Anderson, Narquis Barak, Greg Bautista, Lissa Bayang, Jeremy M. Beckford, Nanette Benbow, Trista Bingham, Barbara Bolden, Kathleen A. Brady, Mary-Grace Brandt, Sarah Braunstein, Richard Burt, Rosalinda Cano, Sidney Carrillo, Jie Deng, Rose Doherty, Anna Flynn, Colin Flynn, David Forrest, Dawn Fukuda, Danielle German, Sara Glick, Vivian Griffin, Henry Godette, DeAnn Gruber, Emily Higgins, Theresa Ick, Tom Jaenicke, Antonio D. Jimenez, Salma Khuwaja, Monina Klevens, Irene Kuo, Marlene LaLota, Zaida Lopez, Yingbo Ma, Karen MacMaster, Kathryn Macomber, Manya Magnus, Melissa Marzan, Melanie Mattson, David Melton, Sharon Melville, Lisa Metsch, Vanessa Miguelino-Keasling, Maura Miminos, Sandra Miranda De León, Alan Neaigus, Willie Nixon, Chrysanthus Nnumolu, Alicia Novoa, Conall O’Cleirigh, Jenevieve Opoku, Paige Padgett, Jonathon Poe, Nikhil Prachand, H. Fisher Raymond, Hafeez Rehman, Kathleen H. Reilly, Alexis Rivera, William T. Robinson, Yadira Rolón-Colón, Kimi Sato, John-Mark Schacht, Stephanie Masiello Schuette, Ekow Kwa Sey, Shane Sheu, Jennifer Shinefeld, Mark Shpaner, Andrea Sifferman, Amber Sinclair, Lou Smith, Emma Spencer, Ashley Tate, Hanne Thiede, Mark Thrun, Jeff Todd, Veronica Tovar-Moore, Margaret Vaaler, Al Velasco, Carol-Ann Watson, Travis Wendel, Tiffany West, Jianglan White, Ralph Wilmoth, Chris Wittke, Afework Wogayehu, Marcia Wolverton, Pascale Wortley, Meagan C. Zarwell
Journal: MMWR Morbidity and Mortality Weekly Report (2019)

Correct and consistent condom use and human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) are protective against sexual transmission of HIV (1,2). The incidence of HIV infection among Hispanic/Latino men who have sex with men (MSM) in the United States is increasing (3). HIV risk among Hispanic/Latino MSM differs based on their place of birth and years of U.S. residence (4). Data from CDC's National HIV Behavioral Surveillance (NHBS)* for 2011-2017 were analyzed to assess changes in sexual risk behaviors among Hispanic/Latino MSM by place of birth and years of U.S. residence. Overall, condomless anal sex during the previous 12 months increased from 63% in 2011 to 74% in 2017, and PrEP use during the previous 12 months increased from 3% in 2014 to 24% in 2017. Regardless of place of birth, nearly 75% of Hispanic/Latino MSM reported condomless anal sex during 2017. However, because of PrEP use, <60% of non-U.S.-born Hispanic/Latino MSM and <50% of U.S.-born Hispanic/Latino MSM reported unprotected anal sex (condomless anal sex and no PrEP use) during 2017. Results indicate that PrEP can be a vital tool for reducing HIV transmission among Hispanic/Latino MSM, especially those who have condomless anal sex. Interventions to prevent HIV acquisition, including increasing PrEP uptake, could address cultural and linguistic needs of Hispanic/Latino MSM, as well as other barriers to prevention of HIV infection typically faced by all MSM.
Disturbance of B-Cell Homeostasis In Chronic Graft-Versus-Host Disease of the Lung
Authors: Zoya Kuzmina, Roman Weigl, Katharina Krenn, Ventzislav Petkov, Ulrike Koermoeczi, Arno Rottal, Christoph Zielinski, Hildegard T. Greinix, Winfried Pickl
Journal: Blood (2010)
FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
Authors: Sandrine Ettou, Catherine Humbrecht, Blandine Benet, Olivier Kosmider, Nathalie Droin, Odile Beyne-Rauzy, Bruno Quesnel, Catherine Lacombe, Dreyfus Francois, Patrick Mayeux, Eric Solary, Michaëla Fontenay
Journal: Blood (2010)
A Case of Two Young Brothers with Natural-Killer/T-Cell Lymphoma
Authors: Tiffany Tang, Maarja-Liisa Nairismagi, Alvin Yu Jin Ng, Byrappa Venkatesh, Joanne Ngeow, Shao-Tzu Li, Yurike Laurensia, Jing Quan Lim, Sanjanaa Nagarajan, Burton Chia, Jing Tan, Yeow Tee Goh, Miriam Tao, Richard Hong Hui Quek, Mohamad Farid, Soon Thye Lim, Choon Kiat Ong
Journal: Blood (2016)
Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)
Authors: Zuzana Zemanova, Kyra Michalova, Jana Brezinova, Karla Svobodova, Halka Lhotska, Iveta Sarova, Libuse Lizcova, Silvia Izakova, Sarka Ransdorfova, Lenka Pavlistova, Adela Berkova, Karolina Skipalova, Monika Belickova, Magda Siskova, Radana Neuwirtova, Jaroslav Cermak, Tomas Stopka, Anna Jonasova
Journal: Blood (2016)
Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Authors: Seok Lee, Yoo-Jin Kim, Chang-Ki Min, Byung-Sik Cho, Sung-Yong Kim, Ki-Seong Eom, Heeje Kim, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Woo-Sung Min, Chun-Choo Kim
Journal: Blood (2007)
Induction with Velcade®/Dexamethasone Partially Overcomes the Poor Prognosis of t(4;14), but Not That of Del(17p), in Young Patients with Multiple Myeloma.
Authors: Hervé Avet Loiseau, Philippe Moreau, Claire Mathiot, Catherine Charbonnel, Denis Caillot, Thierry Facon, Michel Attal, Lotfi Benboubker, Cyrille Hulin, Gerald Marit, Stéphane Minvielle, Jean-Luc Harousseau
Journal: Blood (2009)
Clinical Significance of LNK (SH2B3) Expression in Pediatric B Cell Precursor Acute Lymphoblastic Leukemia
Authors: Mio Yano, Toshihiko Imamura, Kenichi Sakamoto, Daisuke Asai, Gen Kano, Hajime Hosoi, Takao Deguchi, Yoshiko Hashii, Mikiya Endo, Atsushi Sato, Hirohide Kawasaki, Yoshiyuki Kosaka, Koji Kato, Hiroki Hori, Keiko Yumura, Junichi Hara, Megumi Oda, Stephen T. Oh, Keizo Horibe
Journal: Blood (2014)
The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort
Authors: Maximilian Stahl, Nikolai A Podoltsev, Michelle DeVeaux, Sarah Perreault, Raphaël Itzykson, Ellen K. Ritchie, Mikkael A. Sekeres, Amir T. Fathi, Rami S. Komrokji, Vijaya R. Bhatt, Aref Al-Kali, Thomas Cluzeau, Valeria Santini, Andrew Brunner, Gail J. Roboz, Pierre Fenaux, Mark Litzow, Norbert Vey, Vivek Verma, Ulrich Germing, Pau Montesinos Fernández, Daniel Zelterman, Tae Kon Kim, Thomas Prebet, Steven D Gore, Amer M. Zeidan
Journal: Blood (2016)
Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)
Authors: Wanda Salzer, Barbara Asselin, Jeffrey Supko, Meenakshi Devidas, Nicole Kaiser, Paul V. Plourde, Naomi Winick, Gregory Reaman, Elizabeth Raetz, William L. Carroll, Stephen Hunger
Journal: Blood (2010)
Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient
Authors: Thomas Melchardt, Lukas Weiss, Clemens Hufnagl, Daniel Neureiter, Ralf Kemmerling, Patrick Morre, Ann Boekstegers, Georg Hopfinger, Richard Greil, Alexander Egle
Journal: Blood (2012)
Notch Signaling Mediated By Dll1/4 Notch Ligands Controls the Pathogenesis of Both Multi-Organ System Non-Sclerodermatous and Sclerodermatous Chronic Graft-Versus-Host Disease
Authors: Vedran Radojcic, Ryan P Flynn, Jooho Chung, Jing Du, Eric Perkey, Katelyn Paz, Michael Zaiken, Ann Friedman, Minhong Yan, Christian W. Siebel, Bruce R. Blazar, Ivan Maillard
Journal: Blood (2016)
A Novel Xenograft Model of Cytogenetically Normal Acute Myeloid Leukemia Harboring RUNX1 and ASXL1 Mutations Demonstrates Residual Disease after Anthracycline/Cytarabine-Based Chemotherapy
Authors: Umayal Sivagnanalingam, Marlene Balys, Allison Eberhardt, Nancy Wang, John M. Ashton, Jason H. Mendler
Journal: Blood (2014)
The Devil Is Not As Black As He Is Painted - 3-Year Experience of Treating Newly Diagnosed CML Patients with Imatinib Generics
Authors: Vasily Shuvaev, Mikhail Fominykh, Vera Udaleva, Irina I Zotova, Regina Golovchenko, Dzhariyat Shikhbabaeva, Irina Martynkevich, Lyudmila Martynenko, Marina Ivanova, Natalya Tsybakova, Ekaterina Motyko, Lyubov Polushkina, Nadezhda Potikhonova, Sophya Tyranova, Marina Zenina, Kudrat Abdulkadyrov
Journal: Blood (2016)
Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.
Authors: Monica Balzarotti, Michele Spina, Massimo Magagnoli, Teodoro Chisesi, Antonello Pinto, Luca Castagna, Monica Demarco, Mariagrazia Michieli, Andrea Nozza, Umberto Tirelli, Armando Santoro
Journal: Blood (2005)
Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia
Authors: Alka Puri, Shawn Mahmood, Bernadette Maertens, Monika Davare, Stephen E Kurtz, Cristina E. Tognon, Christopher O. Eden, Johannes Elferich, Ujwal Shinde, Brian J. Druker, Jack W. Singer, Anupriya Agarwal
Journal: Blood (2016)
Patient (Pt)-Driven Discontinuation of Tyrosine Kinase Inhibitor Theray in Chronic Phase Chronic Myeloid Leukemia (CML) - Single Institution Experience
Authors: Ohad Benjamini, Hagop M. Kantarjian, Mary Beth Rios, Elias Jabbour, Susan O'Brien, Preetesh Jain, Stefan Faderl, Guillermo Garcia-Manero, Farhad Ravandi, Gautam Borthakur, Alfonso Quintás-Cardama, Jorge E. Cortes
Journal: Blood (2012)
ILC3 deficiency and generalized ILC abnormalities in DOCK8‐deficient patients
Authors: Ahmet Eken, Murat Cansever, Fatma Zehra Okus, Serife Erdem, Ercan Nain, Zehra Busra Azizoglu, Yesim Haliloglu, Musa Karakukcu, Alper Ozcan, Omer Devecioglu, Guzide Aksu, Zeynep Arikan Ayyildiz, Erdem Topal, Elif Karakoc Aydiner, Ayca Kiykim, Ayse Metin, Funda Cipe, Aysenur Kaya, Hasibe Artac, Ismail Reisli, Sukru N. Guner, Vedat Uygun, Gulsun Karasu, Hamiyet Dönmez Altuntas, Halit Canatan, Mohamed Oukka, Ahmet Ozen, Talal A. Chatila, Sevgi Keles, Safa Baris, Ekrem Unal, Turkan Patiroglu
Journal: Allergy (2019)

Abstract Background Dedicator of cytokinesis 8 (DOCK8) deficiency is the main cause of the autosomal recessive hyper‐IgE syndrome (HIES). We previously reported the selective loss of group 3 innate lymphoid cell (ILC) number and function in a Dock8 ‐deficient mouse model. In this study, we sought to test whether DOCK8 is required for the function and maintenance of ILC subsets in humans. Methods Peripheral blood ILC1‐3 subsets of 16 DOCK8‐deficient patients recruited at the pretransplant stage, and seven patients with autosomal dominant (AD) HIES due to STAT3 mutations, were compared with those of healthy controls or post‐transplant DOCK8‐deficient patients (n = 12) by flow cytometry and real‐time qPCR. Sorted total ILCs from DOCK8‐ or STAT3‐mutant patients and healthy controls were assayed for survival, apoptosis, proliferation, and activation by IL‐7, IL‐23, and IL‐12 by cell culture, flow cytometry, and phospho‐flow assays. Results DOCK8‐deficient but not STAT3‐mutant patients exhibited a profound depletion of ILC3s, and to a lesser extent ILC2s, in their peripheral blood. DOCK8‐deficient ILC1‐3 subsets had defective proliferation, expressed lower levels of IL‐7R, responded less to IL‐7, IL‐12, or IL‐23 cytokines, and were more prone to apoptosis compared with those of healthy controls. Conclusion DOCK8 regulates human ILC3 expansion and survival, and more globally ILC cytokine signaling and proliferation. DOCK8 deficiency leads to loss of ILC3 from peripheral blood. ILC3 deficiency may contribute to the susceptibility of DOCK8‐deficient patients to infections.
Mucin-1 (MUC1) Oncoprotein in Multiple Myeloma Cells Inhibits the Th1 Responses By Down Regulating the Expression of Mir-200c and up-Regulating the PDL1 Expression
Authors: Hasan Rajabi, Maxwell Douglas Coll, Jacalyn Rosenblatt, Li Yin, Dina Stroopinsky, Katarina Luptakova, Baldev Vasir, Athalia Rachel Pyzer, Kristen Palmer, Michal Bar-Natan, Salvia Jain, Poorvi Somaiya, Jon Arnason, Donald Kufe, David Avigan
Journal: Blood (2014)
Prophylactic Natural Killer Cell Immunotherapy Following HLA-Haploidentical Hematopoietic Cell Transplantation Prevents Relapse and Improves Survival in Patients with High-Risk Hematological Malignancies
Authors: Monica Thakar, Parameswaran Hari, David G. Maloney, Carolyn A. Keever-Taylor, Lori Jones, Shelly Heimfeld, Rainer F. Storb, Brenda M. Sandmaier
Journal: Blood (2016)
The PcG Protein L3MBTL1 Transcriptionally Represses Human Embryonic and Fetal Globin Genes: a Novel Prospect for HbF Activation
Authors: Fabiana Perna, Ruben Hoya-Arias, Ly Phuong Vu, Fan Liu, Francesca Voza, Xinyang Zhao, Lan Wang, Takashi Asai, Delphine Ndiaye-Lobry, Silvia Menendez, Stephen D Nimer
Journal: Blood (2010)
Deferasirox (Exjade®) Is Effective and Well Tolerated in Chelation-Naive and Previously Chelated Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS).
Authors: Mathias Schmid, Agnès Guerci-Bresler, Matteo Della Porta, Kerry Taylor, Dany Habr, Gabor Domokos, Bernard Roubert, Christian Rose, Norbert Gattermann
Journal: Blood (2009)
Distinct Roles of CHK2 and Cell Death in Suppressing Oncogenic Potential of Tandem DNA Breaks in Human Hematopoietic Stem Cells
Authors: Shahar Biechonski, Muhammad Yassin, Nasma Aqaqe, Leonid Olender, Melanie Rall, Lisa Wiesmüller, Yael Raz, Katia Beider, Arnon Nagler, Michael Milyavsky
Journal: Blood (2016)
Erythropoietin Stimulating Agents (ESAs): Reassessment of Use in Cancer and Chronic Kidney Disease (CKD) Settings in the United States, Canada, and Europe.
Authors: Charles L Bennett, Athena T Samaras, June M McKoy, Beatrice J Edwards, Mi Zheng, Matthew J Fisher, Simone N Boyle, Steven M Trifilio, Monica Boen, Dianne Deleon, Dennis P West
Journal: Blood (2009)
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
Authors: Amir Rosenblatt, Patricia Udaondo, José Cunha-Vaz, Sobha Sivaprasad, Francesco Bandello, Paolo Lanzetta, Laurent Kodjikian, Michaella Goldstein, Zohar Habot-Wilner, Anat Loewenstein, Amir Rosenblatt, Patricia Udaondo, Jose Juan Escobar, Geeta Menon, Sobha Sivaprasad, Borja Corcostegui, Urban Eriksson, Anna Boixadera, Francesco Bandello, Laura Sararols, Laurent Kodjikian, Sebastien Guigou, Monica Varano, João Figueira, Ayalla Pollack, Pascale Massin, Paolo Carpineto, Nicola Recchimurzo, Frederic Matonti, Kati Kinnunen, Paolo Lanzetta, Florence Coscas, Edoardo Midena, João Nascimento, Felix Armada, José Cunha-Vaz, Nir Sorkin, Zohar Habot- Wilner, Michaella Goldstein, Anat Loewenstein
Journal: Ophthalmology (2019)

To evaluate the efficacy, effect profile, and safety of dexamethasone implant on diabetic macular edema (DME) in a real-life setting, further comparing results by DME duration, previous treatment status, and diabetic control.A multicenter, retrospective cohort of 340 DME eyes of 287 patients from 25 clinical sites from 8 countries.Data were analyzed in 2 perspectives: per injection, in which all measurements were grouped and baseline was defined as the day of injection, and thus the pharmacodynamics of single injections could be assessed; and injection series, defined as 2 or more injections with 3 to 6 months between injections analyzing the outcome 3 to 6 months after the last injection.Primary outcome was improvement of 15 or more letters in best-corrected visual acuity (BCVA) from baseline. Secondary outcomes included improvement of 10 letters or more in BCVA, change in central macular thickness (CMT), and time to maximum improvement and safety.Overall, 762 injections were administered to 340 eyes of 287 patients. Injection series analysis included 171 series in 171 eyes of 150 patients, for a total of 444 injections, with a mean follow-up of 1.7±0.8 years. Of the 762 injections analyzed per injection, 22.7% achieved a 15-letter or more improvement, and 37.8% achieved a 10-letter or more improvement. Mean time to peak improvement was 81.9±39.7 days. Mean maximum change in CMT was -174±171 μm. Overall, 7.6% lost 15 or more letters. More eyes with early DME gained 10 or more letters and fewer eyes lost 10 or more letters compared with eyes with late DME (47.4% vs. 33.9% [P = 0.001] and 8.2% vs. 13.5% [P = 0.029], respectively). Patients with controlled diabetes showed greater CMT reduction (P = 0.0002). A higher percentage of treatment-naive patients gained 10 or 15 letter or more in BCVA (P = 0.001 and P = 0.006, respectively). Intraocular pressure elevation of more than 25 mmHg was found following 7.9% of injections; no endophthalmitis was reported.Dexamethasone implant is an effective and safe treatment for DME. Peak improvement was achieved 3 months after injection and dissipated thereafter. Clinicians and providers may consider shortening treatment intervals.
Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).
Authors: Thomas Prebet, Mohamad Mohty, Patrick Ladaique, Christian Chabannon, Catherine Faucher, Sabine Furst, Hugues de Lavallade, Jean El-Cheikh, Patrice Viens, Jean-Albert Gastaut, Didier Blaise
Journal: Blood (2006)
Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.
Authors: Abdulwahab J. Al-Tourah, Kerry J. Savage, Karamjit K. Gill, Richard J. Klasa, Laurie H. Sehn, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors
Journal: Blood (2007)
10-Year Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT) in Adolescent and Young Adults (AYA)
Authors: Rabi Hanna, Lisa Rybicki, Donna Abounader, Brian J. Bolwell, Robert M Dean, Hien K. Duong, Aron Flagg, Aaron T. Gerds, Betty K. Hamilton, Brian T. Hill, Matt E. Kalaycio, Ron Sobecks, Navneet S. Majhail
Journal: Blood (2014)
Allogeneic Stem Cell Tranplantation (allo-SCT) for Adult Patients with Active Refractory/Relapsed Hematological Malignancies: a Survey From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC).
Authors: Patrice Chevallier, Noel Milpied, Karin Bilger, Gérard Socié, Ibrahim Yakoub-Agha, Mauricette Michallet, Jean-Yves Cahn, Yves Beguin, Jacques-Olivier Bay, Didier Blaise, Francois Guilhot, Christian Berthou, Eric Deconinck, Nicole Raus, Mohamad Mohty
Journal: Blood (2010)
Identification of Risk Factors for Tumour Lysis Syndrome in Patients with Acute Myeloid Leukaemia: Development of a Prognostic Score.
Authors: Pau Montesinos, Guillermo Martin, Mariluz Perez-Sirvent, Armando V. Mena-Duran, Ignacio Lorenzo, Martinez Jesus, Javier De La Rubia, Noemi Puig, Susana Cantero, Jaime Sanz, Carlos Pastorini, Guillermo F. Sanz, Miguel A. Sanz
Journal: Blood (2005)
Soluble Vascular Cell Adhesion Molecule Levels, Endothelin-1 and Endothelial Nitric Oxide Synthase Gene Polymorphisms: Association with Clinical Symptoms in Sickle Cell Anemia.
Authors: Wendell Vilas-Boas, Camylla Vilas Boas Figueiredo, Bruno A. V. Cerqueira, Thassila Pitanga, Angela Zanette, Mitermayer Reis, Marilda Goncalves
Journal: Blood (2012)
Patients Receiving IL-2 Activated Donor NK Cells Show Lower Incidence of Severe GvHD after Haploidentical SCT.
Authors: Chiara Gentilini, Urte Hilbers, Volker Huppert, Christoph Loddenkemper, Arne Müßig, Constanze Kliem, Thoralf Lange, Nadezda Basara, Marcus Uhrberg, Eckhard Thiel, Dietger W. Niederwieser, Lutz Uharek
Journal: Blood (2007)
Whole-Exome Analysis Of DLBCL Tumors Reveals a Unique Genetic Signature Associated With Aggressive Disease
Authors: Anne J Novak, Yan W Asmann, Matthew J Maurer, Chen Wang, Susan L Slager, Lucy S. Hodge, Michelle Manske, Tammy Price-troska, Michael Zimmerman, Stephen M Ansell, Thomas E. Witzig, Andrew L Feldman, Ahmet Dogan, Brian K Link, Thomas M. Habermann, James Cerhan
Journal: Blood (2013)